Non-pharmacological interventions in non-alcoholic fatty liver disease patients.

about

Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.Nutrition, inflammation and liver-spleen axis.Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease.

P2860

Q36292252-18024EC2-0E16-4B5F-8E60-DC29A6EF947D Q40086170-1DBAF833-3F23-4B73-9CD5-D6902A26EFD3 Q41583750-9E8C30ED-AA8F-4996-96CF-69FC9D4A3301

P2860

Non-pharmacological interventions in non-alcoholic fatty liver disease patients.

Item

http://www.wikidata.org/entity/Q39067374

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Non-pharmacological interventions in non-alcoholic fatty liver disease patients.

@en

Non-pharmacological interventions in non-alcoholic fatty liver disease patients.

@nl

type

Item

label

Non-pharmacological interventions in non-alcoholic fatty liver disease patients.

@en

Non-pharmacological interventions in non-alcoholic fatty liver disease patients.

@nl

prefLabel

Non-pharmacological interventions in non-alcoholic fatty liver disease patients.

@en

Non-pharmacological interventions in non-alcoholic fatty liver disease patients.

@nl

P1476

Non-pharmacological interventions in non-alcoholic fatty liver disease patients.

@en

P2093

Vlad Ratziu

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy

Adherence to Mediterranean diet and health status: meta-analysis

Fructose consumption as a risk factor for non-alcoholic fatty liver disease

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.

Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans

P304

90-96

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/LIV.13311

http://www.w3.org/2001/XMLSchema#string

P478

37 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28052636

http://www.w3.org/2001/XMLSchema#string

Non-pharmacological interventions in non-alcoholic fatty liver disease patients.

about

P2860

P2860

Non-pharmacological interventions in non-alcoholic fatty liver disease patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698